Progress in Mind
Discover the archives of schizophrenia and related articles
Choose a channel
Check out the different Progress in Mind content channels.
Schizophrenia
Satellite symposium
Early stage schizophrenia and the road to recovery
During this symposium, Professor Nadja Marić, Serbia, discussed the patient’s journey through...
Schizophrenia
Satellite symposium
Engaging patients with schizophrenia in decision-making to improve outcomes
Medication adherence is a challenge for many patients, especially with chronic diseases, such as...
Schizophrenia
Satellite symposium
Seize opportunities to improve long-term outcome
Given the strong evidence that long acting treatment improves functional outcomes, we need to be...
Depression, Schizophrenia
Congress highlights
Lifestyle, the gut, and mental health
Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of...
Mental health
Congress highlights
Why is greater investment key to better mental health?
Every individual with a mental health disorder has a unique experience. Understanding this...
Mental health
Article
No health without mental health
The 10–25-year lower life expectancy of people with severe mental health disorders compared...
Mental health
Article
World Mental Health Day 2020 — addressing stigma and discrimination to achieve Mental Health for All
The theme for World Mental Health Day 2020 is Mental Health for All: Greater Investment, Greater...
Schizophrenia
Satellite symposium
Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?
Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes....
Mental health
Article
Digital technologies — an opportunity to achieve Mental Health for All
Digital technologies have the potential to transform the theme for World Mental Health Day 2020...
Schizophrenia
Article
Are antipsychotics needed for the long-term treatment of schizophrenia?
‘Do we need antipsychotics for the long-term treatment of schizophrenia?’ was the title...
Schizophrenia
Congress highlights
Real world study casts new light on potential of polypharmacy
The fact that 20-25% of patients with schizophrenia are treated with more than one antipsychotic1...
Schizophrenia
Congress highlights
Addressing the unmet need of cognitive dysfunction in schizophrenia
Metacognition needs to be an important component of cognitive remediation therapy (CRT) to...